K. M. H. Vangangelt

Standardization of the tumor-stroma ratio scoring method for breast cancer research

A. Green, E. Rakha, W. Mesker, 2022, Breast Cancer Research and Treatment.

Standardization of the tumor-stroma ratio scoring method for breast cancer research

A. Green, E. Rakha, W. Mesker, 2022, Breast Cancer Research and Treatment.

The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer

H. Putter, A. Green, R. Tollenaar, 2020, International journal of cancer.

The intra-tumoural stroma in patients with breast cancer increases with age

H. Putter, A. Green, R. Tollenaar, 2019, Breast Cancer Research and Treatment.

Serum N-glycan profiles differ for various breast cancer subtypes

W. Mesker, S. Nicolardi, Y. V. D. van der Burgt, 2021, Glycoconjugate Journal.

The prognostic value of tumor–stroma ratio in tumor‐positive axillary lymph nodes of breast cancer patients

R. Tollenaar, P. Kuppen, W. Mesker, 2018, International journal of cancer.

The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review

R. Tollenaar, W. Mesker, G. V. van Pelt, 2018, Breast Cancer Research and Treatment.

Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma

H. Putter, R. Tollenaar, P. Kuppen, 2017, Breast Cancer Research and Treatment.